FDA Approves Edwards Lifesciences’ PASCAL Precision System for Tricuspid Valve Repair

Bitget2026/10/21 13:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

FDA approved Edwards Lifesciences’ PASCAL Precision system for tricuspid valve repair in patients with symptomatic severe tricuspid regurgitation.
The agency also cleared PASCAL Ace with Capture Clarity for degenerative mitral valve repair, adding fluoroscopic indicators to confirm leaflet capture.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202610210900BIZWIRE_USPR_____20261021_BW489439) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

FDA Approves Edwards Lifesciences’ PASCAL Precision System for Tricuspid Valve Repair

You may also like

Crypto prices